MYO Stock Overview
A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Myomo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.06 |
| 52 Week High | US$5.58 |
| 52 Week Low | US$0.43 |
| Beta | 1.5 |
| 1 Month Change | 18.02% |
| 3 Month Change | 37.63% |
| 1 Year Change | 792.11% |
| 3 Year Change | -57.17% |
| 5 Year Change | -84.79% |
| Change since IPO | -98.17% |
Recent News & Updates
Shareholder Returns
| MYO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.4% | -0.2% | -0.2% |
| 1Y | 792.1% | 5.2% | 28.2% |
Return vs Industry: MYO exceeded the US Medical Equipment industry which returned 4.2% over the past year.
Return vs Market: MYO exceeded the US Market which returned 27.7% over the past year.
Price Volatility
| MYO volatility | |
|---|---|
| MYO Average Weekly Movement | 15.2% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MYO's share price has been volatile over the past 3 months.
Volatility Over Time: MYO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 104 | Paul Gudonis | myomo.com |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device.
Myomo, Inc. Fundamentals Summary
| MYO fundamental statistics | |
|---|---|
| Market cap | US$111.17m |
| Earnings (TTM) | -US$9.34m |
| Revenue (TTM) | US$19.55m |
6.0x
P/S Ratio-12.5x
P/E RatioIs MYO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MYO income statement (TTM) | |
|---|---|
| Revenue | US$19.55m |
| Cost of Revenue | US$6.38m |
| Gross Profit | US$13.17m |
| Other Expenses | US$22.51m |
| Earnings | -US$9.34m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 67.39% |
| Net Profit Margin | -47.77% |
| Debt/Equity Ratio | 0% |
How did MYO perform over the long term?
See historical performance and comparison